These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30224488)

  • 21. Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice.
    Goldstone DC; Walker PA; Calder LJ; Coombs PJ; Kirkpatrick J; Ball NJ; Hilditch L; Yap MW; Rosenthal PB; Stoye JP; Taylor IA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9609-14. PubMed ID: 24979782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular localisation of Fv1.
    Yap MW; Stoye JP
    Virology; 2003 Mar; 307(1):76-89. PubMed ID: 12667816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses.
    Arnaud F; Caporale M; Varela M; Biek R; Chessa B; Alberti A; Golder M; Mura M; Zhang YP; Yu L; Pereira F; Demartini JC; Leymaster K; Spencer TE; Palmarini M
    PLoS Pathog; 2007 Nov; 3(11):e170. PubMed ID: 17997604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene.
    Bénit L; De Parseval N; Casella JF; Callebaut I; Cordonnier A; Heidmann T
    J Virol; 1997 Jul; 71(7):5652-7. PubMed ID: 9188643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The design of artificial retroviral restriction factors.
    Yap MW; Mortuza GB; Taylor IA; Stoye JP
    Virology; 2007 Sep; 365(2):302-14. PubMed ID: 17493656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
    Bishop KN; Bock M; Towers G; Stoye JP
    J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retroviral capsid determinants of Fv1 NB and NR tropism.
    Stevens A; Bock M; Ellis S; LeTissier P; Bishop KN; Yap MW; Taylor W; Stoye JP
    J Virol; 2004 Sep; 78(18):9592-8. PubMed ID: 15331691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Megabat-Favored, CA-Dependent Susceptibility to Retrovirus Infection.
    Ohkura S; Horie M; Shimizu M; Nakagawa S; Osanai H; Miyagawa Y; Morita R
    J Virol; 2023 Mar; 97(3):e0180322. PubMed ID: 36779757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1.
    Hilditch L; Matadeen R; Goldstone DC; Rosenthal PB; Taylor IA; Stoye JP
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5771-6. PubMed ID: 21436027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
    Kozak CA; Chakraborti A
    Virology; 1996 Nov; 225(2):300-5. PubMed ID: 8918916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-vertebrate comparative genomics unmasks retrovirus macroevolution.
    Hayward A; Cornwallis CK; Jern P
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):464-9. PubMed ID: 25535393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIM5 Retroviral Restriction Activity Correlates with the Ability To Induce Innate Immune Signaling.
    Lascano J; Uchil PD; Mothes W; Luban J
    J Virol; 2016 Jan; 90(1):308-16. PubMed ID: 26468522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins.
    Perez-Caballero D; Soll SJ; Bieniasz PD
    PLoS Pathog; 2008 Oct; 4(10):e1000181. PubMed ID: 18927623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic map of the region surrounding the retrovirus restriction locus, Fv1, on mouse chromosome 4.
    Stoye JP; Kaushik N; Jeremiah S; Best S
    Mamm Genome; 1995 Jan; 6(1):31-6. PubMed ID: 7719023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous Retroviruses in the Genomics Era.
    Johnson WE
    Annu Rev Virol; 2015 Nov; 2(1):135-59. PubMed ID: 26958910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convergent Co-option of the Retroviral
    Wang J; Gong Z; Han GZ
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular diversity and phenotypic pleiotropy of ancient genomic regulatory loci derived from human endogenous retrovirus type H (HERVH) promoter LTR7 and HERVK promoter LTR5_Hs and their contemporary impacts on pathophysiology of Modern Humans.
    Glinsky GV
    Mol Genet Genomics; 2022 Nov; 297(6):1711-1740. PubMed ID: 36121513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral restriction factors in mice.
    Nair S; Rein A
    Virus Res; 2014 Nov; 193():130-4. PubMed ID: 25018022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of endogenous gammaretroviruses and variants of the Fv1 restriction gene in individual mouse strains and strain subgroups.
    Skorski M; Bamunusinghe D; Liu Q; Shaffer E; Kozak CA
    PLoS One; 2019; 14(7):e0219576. PubMed ID: 31291374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capsid-binding retrovirus restriction factors: discovery, restriction specificity and implications for the development of novel therapeutics.
    Sanz-Ramos M; Stoye JP
    J Gen Virol; 2013 Dec; 94(Pt 12):2587-2598. PubMed ID: 24026671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.